Showing results (191-200 of 308) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|July 22, 2021
Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical TrialsSatoshi Ushijima, Naoki Matsumaru, Katsura TsukamotoPharmaceutical Medicine|March 13, 2022
Medical Affairs and Innovative Medicinal Product Strategy DevelopmentAndriy Krendyukov, Dévi NasyPharmaceutical Medicine|March 6, 2022
Medical Affairs Transformation in Specialty Pharma: Next-Level Collaboration at the CoreAntony Fulford-Smith, Emma Leah, Anie Azroyan, et al.Pharmaceutical Medicine|February 4, 2021
The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested SolutionsMagdalena Bujar, Neil McAuslane, Lawrence LibertiPharmaceutical Medicine|December 28, 2011
Advances in Gene Delivery SystemsKenya Kamimura, Takeshi Suda, Guisheng Zhang, et al.Pharmaceutical Medicine|August 22, 2017
Measuring and Improving Physician Knowledge of Safety Risks Using Traditional and Online Methods in PharmacovigilanceAlexander Liede, Justyna Amelio, James Bennett, et al.Pharmaceutical Medicine|June 4, 2026
Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of LevocarnitineStephen Tomlin, Chris Mühlhausen, Andriy Krendyukov, et al.Pharmaceutical Medicine|April 18, 2023
Value and Implementation of the Aggregate Safety Assessment PlanBarbara A Hendrickson, Anupam Agarwal, Dimitri Bennett, et al.Pharmaceutical Medicine|December 15, 2025
Evaluating the Readability of Clinical Trial Content for Patients on Pharmaceutical Company WebsitesChristopher Felix BrewerPharmaceutical Medicine|December 10, 2025
Studies of Cannabinoid-Based Products in ClinicalTrials.gov: A Scoping ReviewMargaret Haney, Ziva D Cooper, Hannah VanLaanen, et al.Pageof 31